Literature DB >> 6780999

Differential effects of morphine on food and water intake in food deprived and freely-feeding rats.

D J Sanger, P S McCarthy.   

Abstract

In two experiments the effects of a range of doses of morphine (1, 3, 10 and 30 mg/kg) on the food and water consumption of rats were studied. The results of the first experiment showed that in 24 h food-deprived rats, morphine reduced levels of food and water intake. The duration of these actions was dependent upon dose, with only the highest dose (30 mg/kg) producing any effect persisting for longer than 4 hr. In contrast a second experiment showed that morphine increased levels of food and water intake in non-deprived animals. The effect on food intake was most apparent when measurements were taken at 2 hr and after 4 h after drug administration, while water intake remained above control levels for over 6 h. This study shows that the actions of morphine on ingestion of food and water are affected by food deprivation, and the results are consistent with the hypothesised role of endogenous opiates in the mediation of such behaviour.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6780999     DOI: 10.1007/BF00433813

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  Behavioral effects of separate and combined administration of naloxone and d-amphetamine.

Authors:  S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1974-04       Impact factor: 4.030

2.  The effects of opiate antagonists on food intake are stereospecific.

Authors:  D J Sanger; P S McCarthy; G Metcalf
Journal:  Neuropharmacology       Date:  1981-01       Impact factor: 5.250

3.  Evidence that opiate receptors mediate suppression of hypertonic saline-induced drinking in the mouse by narcotic antagonists.

Authors:  D R Brown; S G Holtzman
Journal:  Life Sci       Date:  1980-05-05       Impact factor: 5.037

4.  Interaction of amphetamine and naloxone in feeding behavior in guinea pigs.

Authors:  R Schulz; M Wüster; A Herz
Journal:  Eur J Pharmacol       Date:  1980-05-16       Impact factor: 4.432

5.  Identification of two related pentapeptides from the brain with potent opiate agonist activity.

Authors:  J Hughes; T W Smith; H W Kosterlitz; L A Fothergill; B A Morgan; H R Morris
Journal:  Nature       Date:  1975-12-18       Impact factor: 49.962

6.  Disturbed patterns of behaviour in morphine tolerant and abstinent rats.

Authors:  R Kumar; E Mitchell; I P Stolerman
Journal:  Br J Pharmacol       Date:  1971-07       Impact factor: 8.739

7.  Naloxone-induced suppression of food intake in normal and hypothalamic obese rats.

Authors:  B M King; F X Castellanos; A J Kastin; M C Berzas; M D Mauk; G A Olson; R D Olson
Journal:  Pharmacol Biochem Behav       Date:  1979-12       Impact factor: 3.533

8.  beta-Endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa).

Authors:  D L Margules; B Moisset; M J Lewis; H Shibuya; C B Pert
Journal:  Science       Date:  1978-12-01       Impact factor: 47.728

9.  Morphine selectively influences macronutrient intake in the rat.

Authors:  R Marks-Kaufman; R B Kanarek
Journal:  Pharmacol Biochem Behav       Date:  1980-03       Impact factor: 3.533

10.  Naloxone reduces fluid intake: effects of water and food deprivation.

Authors:  N L Ostrowski; T L Foley; M D Lind; L D Reid
Journal:  Pharmacol Biochem Behav       Date:  1980-03       Impact factor: 3.533

View more
  26 in total

1.  The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine.

Authors:  Aaron N A Verty; Malini E Singh; Iain S McGregor; Paul E Mallet
Journal:  Psychopharmacology (Berl)       Date:  2003-04-17       Impact factor: 4.530

2.  β-Endorphin antagonizes the effects of α-MSH on food intake and body weight.

Authors:  Roxanne Dutia; Kana Meece; Shveta Dighe; Andrea J Kim; Sharon L Wardlaw
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

3.  Effects of nalmefene on feeding in humans. Dissociation of hunger and palatability.

Authors:  M R Yeomans; P Wright; H A Macleod; J A Critchley
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  A novel operant-based behavioral assay of mechanical allodynia in the orofacial region of rats.

Authors:  Eric L Rohrs; Heidi E Kloefkorn; Emily H Lakes; Brittany Y Jacobs; John K Neubert; Robert M Caudle; Kyle D Allen
Journal:  J Neurosci Methods       Date:  2015-03-28       Impact factor: 2.390

5.  Gene expression profiling following short-term and long-term morphine exposure in mice uncovers genes involved in food intake.

Authors:  A Anghel; C A M Jamieson; X Ren; J Young; R Porche; E Ozigbo; D E Ghods; M L Lee; Y Liu; K Lutfy; T C Friedman
Journal:  Neuroscience       Date:  2010-02-06       Impact factor: 3.590

6.  Morphine acts in the parabrachial nucleus, a pontine viscerosensory relay, to produce discriminative stimulus effects.

Authors:  T V Jaeger; D van der Kooy
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Reinforcer interactions under concurrent schedules of food, water, and intravenous morphine.

Authors:  S I Dworkin; G F Guerin; N E Goeders; D R Cherek; J D Lane; J E Smith
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 8.  The effects of opioids and opioid analogs on animal and human endocrine systems.

Authors:  Cassidy Vuong; Stan H M Van Uum; Laura E O'Dell; Kabirullah Lutfy; Theodore C Friedman
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

9.  Stimulation of food intake following opiate agonists in rats but not hamsters.

Authors:  M T Lowy; G K Yim
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Opioid system in the medial prefrontal cortex mediates binge-like eating.

Authors:  Angelo Blasio; Luca Steardo; Valentina Sabino; Pietro Cottone
Journal:  Addict Biol       Date:  2013-01-24       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.